Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

McMaster University

$17,500.00

Characterizing the protein-protein interactions associated with Ataxin-1

EF 2018-19

Résumé
Spinocerebellar ataxia type 1 (SCA1) is a neurodegenerative disease characterized by progressive loss of coordination and balance, difficulties with speech and swallowing, muscle stiffness, and weakness in the muscles that control eye movement. Currently, there is no treatment for SCA1. Patients typically survive 10-30 years after diagnosis. This disease is caused by a mutation in the ataxin-1 protein, specifically the expansion of glutamine repeats in the coding region of the protein. Despite our understanding that the mutated protein causes toxicity primarily in the cerebellum, the function of ataxin-1 is unknown. Ataxin-1 has been shown to interact with several proteins involved in gene expression, and these interactions are dysregulated in mice with SCA1. To our knowledge, the interaction of ataxin-1 with these proteins has not been studied in the context of humans. In several other disease models, mice do not recapitulate human disease, emphasizing the importance of human model systems in disease research. We hypothesize that the protein interactions associated with ataxin-1 will be dysregulated in cells taken from SCA1 patients. In this study, we aim to develop a SCA1 patient cell line with fluorescently tagged ataxin-1, which allows for the visualization of ataxin-1 protein interactions. The protein interactions in SCA1 patient cell lines can be compared to that in unaffected cells, in order to identify differences in ataxin-1 protein interactions. This could provide valuable insight into the normal function of ataxin-1, as well as potential mechanisms for SCA1 development.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
406508
Name
Graham Katherine J
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Characterizing the protein-protein interactions associated with Ataxin-1
Programtype2
Studentship Programs
Orgnameinp2
McMaster University
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Ataxin-1; Polyglutamine Expansion Disease; Protein-Protein Interactions; Spinocerebellar Ataxia Type I
Abstract
Spinocerebellar ataxia type 1 (SCA1) is a neurodegenerative disease characterized by progressive loss of coordination and balance, difficulties with speech and swallowing, muscle stiffness, and weakness in the muscles that control eye movement. Currently, there is no treatment for SCA1. Patients typically survive 10-30 years after diagnosis. This disease is caused by a mutation in the ataxin-1 protein, specifically the expansion of glutamine repeats in the coding region of the protein. Despite our understanding that the mutated protein causes toxicity primarily in the cerebellum, the function of ataxin-1 is unknown. Ataxin-1 has been shown to interact with several proteins involved in gene expression, and these interactions are dysregulated in mice with SCA1. To our knowledge, the interaction of ataxin-1 with these proteins has not been studied in the context of humans. In several other disease models, mice do not recapitulate human disease, emphasizing the importance of human model systems in disease research. We hypothesize that the protein interactions associated with ataxin-1 will be dysregulated in cells taken from SCA1 patients. In this study, we aim to develop a SCA1 patient cell line with fluorescently tagged ataxin-1, which allows for the visualization of ataxin-1 protein interactions. The protein interactions in SCA1 patient cell lines can be compared to that in unaffected cells, in order to identify differences in ataxin-1 protein interactions. This could provide valuable insight into the normal function of ataxin-1, as well as potential mechanisms for SCA1 development.
Competitiondate
201812
Approvedterm2
1 yr 0 mth
Pinamesdelim
Graham, Katherine J
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~